Finally, tumor-relevant behaviors of ESCC cells were observed in different treatment groups, and finding that adding SC-79 promoted ESCC cell proliferation, migration, and invasion and counteracted the inhibitory effect of SPARCL1 on ESCC cells (Figures 5D–F). This evidence concerns the gene SPARCL1 and esophageal squamous cell carcinoma.